Toronto, ON (PRWEB) November 01, 2022 Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical
/PRNewswire/ GenesisCare, a leading provider of integrated cancer care globally, and Prelude Corporation (PreludeDx(TM)), a leader in molecular diagnostics.
/PRNewswire/ GenesisCare, a leading provider of integrated cancer care globally, and Prelude Corporation (PreludeDx(TM)), a leader in molecular diagnostics.
/PRNewswire/ Prelude Corporation (PreludeDxä), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced today that.
Cedars-Sinai physicians and scientists will share the results of new research aimed at improving the treatment of digestive diseases during the international me